Analysis of the US Hospital Tumor Marker Testing Market

This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: 

• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years. 

• Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. 

• Test volume and sales forecasts for 40 tumor markers performed in US hospitals. 

• Current instrumentation technologies and feature comparison of leading analyzers. 

• Sales and market shares of leading suppliers. 

• Emerging diagnostic technologies and their potential market applications. 

• Product development opportunities. 

• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 

• Business opportunities and strategic recommendations for suppliers. 

            Contains 567 pages and 50 tables